2026. Metabolic Reprogramming of Leukemia Stem Cells as a Novel Therapeutic Target for Relapsed Acute Myeloid Leukemia. Pakistan Journal of Medical & Cardiological Review. 5, 1 (Mar. 2026), 5786–5812. DOI:https://doi.org/10.5281/zenodo.22067075.